Chronic Pain Epidemiology Forecast
DelveInsight’s ‘Chronic Pain – Epidemiology Forecast—2032’ report delivers an in-depth understanding of chronic pain historical and forecasted epidemiology in the United States, the EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- The EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2019–2032
Chronic Pain Disease Understanding
The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. It may be due to an injury or the brain’s inability to process pain signals properly. Chronic pain can range from mild to severe and is present for long periods (>3 months) and is often the result of a disease that may require ongoing treatment. The most common sources of chronic pain include low back pain, musculoskeletal pain, migraines, fibromyalgia, neuralgia, cancer pain, visceral, and postoperative pain. With many chronic conditions, the cause of the pain is unknown
Chronic Pain Epidemiology
The chronic pain epidemiology report provides insights into the historical and incident patient pool, along with the forecasted trend for all seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool, trends, and assumptions.
Key Findings
The total prevalent cases of chronic pain patients in the 7MM will increase during the study period, i.e., 2019–2032.
The disease epidemiology covered in the report provides historical as well as forecasted chronic pain symptoms epidemiology segmented as the total prevalent cases of chronic pain, severity-specific cases of chronic pain, age-specific cases of chronic pain, and cause-specific cases of chronic pain. The report includes the prevalent cases scenario of chronic pain in the 7MM covering the United States, the EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.
Country-wise Chronic Pain Epidemiology
The epidemiology segment also provides the chronic pain epidemiology data and findings across the United States, the EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The prevalent cases of chronic pain associated in the 7MM countries were around 174 million in 2021.
- As per the estimates, the United States has the highest number of prevalent cases of chronic pain in 2021.
- Among the EU5 countries, the UK had the highest number of prevalent cases of chronic pain, followed by Germany in 2021. On the other hand, Spain had the lowest number of prevalent cases, with about 9 million cases in 2021.
Scope of the Report
- The chronic pain report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
- The Chronic Pain Epidemiology Report and Model provide an overview of chronic pain’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, the UK, and Japan).
- The report provides insight into chronic pain’s historical and forecasted patient pool in seven major markets covering the United States, the EU5 (Germany, Spain, France, Italy, the UK), and Japan.
- The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
- The report assesses the disease risk and burden and highlights the unmet needs of chronic pain.
- The report provides the segmentation of chronic pain epidemiology by the prevalent cases of chronic pain in the 7MM.
- The report provides the chronic pain epidemiology segmentation by severity-specific cases of chronic pain in the 7MM.
- The report provides the chronic pain epidemiology segmentation by age-specific cases of chronic pain in the 7MM.
- The report provides the chronic pain epidemiology segmentation by cause-specific cases of chronic pain in the 7MM.
Report Highlights
- 11-year Forecast of Chronic Pain epidemiology
- 7MM Coverage
- Prevalent Cases of Chronic Pain
- Severity-specific cases of Chronic Pain
- Age-specific Cases of Chronic Pain
- Cause-specific cases of Chronic Pain
KOL Views
We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.
Key Questions Answered
- What are the major factors that will drive the change in the patient population in chronic pain during the forecast period (2019–2032)?
- What are the key findings of chronic pain epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2019–2032)?
- What would be the total number of chronic pain patients across the 7MM during the forecast period (2019–2032)?
- Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019–2032)?
- At what CAGR the patient population is expected to grow in the 7MM during the forecast period (2019–2032)?
- What are the disease risks, burdens, and unmet needs of the chronic pain market?
- What are the current treatment patterns for chronic pain?
Reasons to buy
The chronic pain epidemiology report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the global chronic pain market.
- Quantify patient populations in the global chronic pain market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for chronic pain therapeutics in each market covered.
- Understand the magnitude of the chronic pain population by its prevalence.
- Understand the magnitude of the chronic pain population by its severity-specific cases.
- Understand the magnitude of the chronic pain population by its age-specific cases.
- Understand the magnitude of the chronic pain population by its cause-specific cases.
- The Chronic Pain Epidemiology Report and model were written and developed by Master's and Ph.D. level epidemiologists.
- The Chronic Pain Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
1. Key Insights
2. Report Introduction
3. Chronic Pain Market Overview at a Glance
3.1. Market Share (%) Distribution of Chronic Pain in 2019
3.2. Market Share (%) Distribution of Chronic Pain in 2032
4. Executive Summary of Chronic Pain
5. Disease Background and Overview
5.1. Introduction
5.2. Classification of Chronic Pain
5.3. Characteristic Signs and Symptoms of Chronic Pain
5.3.1. Cancer Pain
5.3.2. Post-operative pain
5.3.3. Neuropathic pain
5.3.4. Chronic headache
5.3.5. Chronic visceral pain
5.3.6. Musculoskeletal (MSK) pain
5.3.7. Fibromyalgia
5.3.8. Osteoarthritis (OA)
5.3.9. Rheumatoid arthritis (RA)
5.3.10. Chronic low back pain
5.4. Risk Factors and Causes of Chronic Pain
5.5. Pathogenesis
5.6. Diagnosis of Chronic Pain
5.6.1. Physical, neurological, and mental health exams
5.6.2. Blood tests and urine analysis
5.6.3. Imaging tests
5.6.4. Nerve tests
5.7. Differential Diagnosis
5.8. Management
5.9. Clinical Practice Guidelines
5.9.1. Diagnostic guidelines
5.9.2. Management Guidelines
6. Epidemiology and Patient Population
6.1. The 7MM Total Prevalent Population of Chronic Pain
6.2. Key Findings
6.3. Assumptions and Rationale
6.4. The United States
6.4.1. Total Prevalent Cases of Chronic Pain in the United States
6.4.2. Severity-specific Cases of Chronic Pain in the United States
6.4.3. Age-specific Cases of Chronic Pain in the United States
6.4.4. Cause-specific Cases of Chronic Pain in the United States
6.5. The EU5
6.5.1. Total Prevalent Cases of Chronic Pain in the EU5
6.5.2. Severity-specific Cases of Chronic Pain in the EU5
6.5.3. Age-specific Cases of Chronic Pain in the EU5
6.5.4. Cause-specific Cases of Chronic Pain in the EU5
6.6. Japan
6.6.1. Total Prevalent Cases of Chronic Pain in Japan
6.6.2. Severity-specific Cases of Chronic Pain in Japan
6.6.3. Age-specific Cases of Chronic Pain in Japan
6.6.4. Cause-specific Cases of Chronic Pain in Japan
7. Patient Journey
8. Appendix
8.1. Bibliography
8.2. Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
List of Tables
Table 1: Summary of Chronic Pain, Market, Epidemiology, and Key Events (2019–2032)
Table 2: Classification of Chronic Pain
Table 3: Summary of Recommendations
Table 4: Recommendations
Table 5: Total Prevalent Population of Chronic Pain in the 7MM (2019–2032)
Table 6: Total Prevalent Cases of Chronic Pain in the United States (2019–2032)
Table 7: Severity-specific Cases of Chronic Pain in the United States (2019–2032)
Table 8: Age-specific Cases of Chronic Pain in the United States (2019–2032)
Table 9: Cause-specific Cases of Chronic Pain in the United States (2019–2032)
Table 10: Total Prevalent Cases of Chronic Pain in the EU5 (2019–2032)
Table 11: Severity-specific Cases of Chronic Pain in the EU5 (2019–2032)
Table 12: Age-specific Cases of Chronic Pain in the EU5 (2019–2032)
Table 13: Cause-specific Cases of Chronic Pain in the EU5 (2019–2032)
Table 14: Total Prevalent Cases of Chronic Pain in Japan (2019–2032)
Table 15: Severity-specific Cases of Chronic Pain in Japan (2019–2032)
Table 16: Age-specific Cases of Chronic Pain in Japan (2019–2032)
Table 17: Cause-specific Cases of Chronic Pain in Japan (2019–2032)
List of Figures
Figure 1: Chronic Pain in ICD-11
Figure 2: Non-pain Symptoms/Signs Exhibited by Chronic Pain Patients
Figure 3: General Characteristics of Pain due to Visceral Pathology
Figure 4: Risk Factors of Chronic Pain
Figure 5: Pain Circuits and Some Manifestations of Chronic Pain
Figure 6: Sensory Neuron Interactions with Central Glial Cells in Neuropathic Pain
Figure 7: Central Sensitization Mechanisms
Figure 8: Recommended Therapies for the Management of OA
Figure 9: Total Prevalent Population of Chronic Pain in the 7MM (2019–2032)
Figure 10: Total Prevalent Cases of Chronic Pain in the United States (2019–2032)
Figure 11: Severity-specific Cases of Chronic Pain in the United States (2019–2032)
Figure 12: Age-specific Cases of Chronic Pain in the United States (2019–2032)
Figure 13: Cause-specific Cases of Chronic Pain in the United States (2019–2032)
Figure 14: Total Prevalent Cases of Chronic Pain in the EU5 (2019–2032)
Figure 15: Severity-specific Cases of Chronic Pain in the EU5 (2019–2032)
Figure 16: Age-specific Cases of Chronic Pain in the EU5 (2019–2032)
Figure 17: Cause-specific Cases of Chronic Pain in the EU5 (2019–2032)
Figure 18: Total Prevalent Cases of Chronic Pain in Japan (2019–2032)
Figure 19: Severity-specific Cases of Chronic Pain in Japan (2019–2032)
Figure 20: Age-specific Cases of Chronic Pain in Japan (2019–2032)
Figure 21: Cause-specific Cases of Chronic Pain in Japan (2019–2032)